Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
language:"English"
topic_facet:"Remission"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=language%3A%22English%22&filter%5B%5D=topic_facet%3A%22Remission%22&lookfor=%22Dalal%2C+Rahul+S%22&type=Person
/vufind/Search/Results?filter%5B%5D=language%3A%22English%22&filter%5B%5D=topic_facet%3A%22Remission%22&lookfor=%22Dalal%2C+Rahul+S%22&type=Person
Search /vufind/Search2/Results?filter%5B%5D=language%3A%22English%22&filter%5B%5D=topic_facet%3A%22Remission%22&lookfor=%22Dalal%2C+Rahul+S%22&type=Person
PubPharm (8)
1
Comparative Long-Term Drug Survival of Vedolizumab, Adalimumab, and Infliximab in Biologic-Naïve Patients with Ulcerative Colitis
enthalten in:
Digestive diseases and sciences
| 2023
von
Dalal, R.
|
McClure, E.
|
Marcus, J.
| +1
Wird geladen...
2
Comparative Long-Term Drug Survival of Vedolizumab, Adalimumab, and Infliximab in Biologic-Naïve Patients with Ulcerative Colitis
enthalten in:
Digestive diseases and sciences
| 2022
von
Dalal, R.
|
McClure, E.
|
Marcus, J.
| +1
Wird geladen...
3
Comparative Long-Term Drug Survival of Vedolizumab, Adalimumab, and Infliximab in Biologic-Naïve Patients with Ulcerative Colitis
enthalten in:
Digestive diseases and sciences
| 2022
von
Dalal, R.
|
McClure, E.
|
Marcus, J.
| +1
Wird geladen...
4
Comparative Long-Term Drug Survival of Vedolizumab, Adalimumab, and Infliximab in Biologic-Naïve Patients with Ulcerative Colitis
enthalten in:
Digestive diseases and sciences
| 2022
von
Dalal, R.
|
McClure, E.
|
Marcus, J.
| +1
Wird geladen...
5
Two Strikes but Not Out : Deep Remission of Ulcerative Colitis with Ustekinumab After Primary Non-response to Infliximab and Vedolizumab
enthalten in:
Digestive diseases and sciences
| 2021
von
Dalal, R.
|
Ananthakrishnan, A.
|
Hamilton, M.
| +1
Wird geladen...
6
Two Strikes but Not Out: Deep Remission of Ulcerative Colitis with Ustekinumab After Primary Non-response to Infliximab and Vedolizumab
enthalten in:
Digestive diseases and sciences
| 2021
von
Dalal, R.
|
Ananthakrishnan, A.
|
Hamilton, M.
| +1
Wird geladen...
7
Two Strikes but Not Out: Deep Remission of Ulcerative Colitis with Ustekinumab After Primary Non-response to Infliximab and Vedolizumab
enthalten in:
Digestive diseases and sciences
| 2021
von
Dalal, R.
|
Ananthakrishnan, A.
|
Hamilton, M.
| +1
Wird geladen...
8
Two Strikes but Not Out: Deep Remission of Ulcerative Colitis with Ustekinumab After Primary Non-response to Infliximab and Vedolizumab
enthalten in:
Digestive diseases and sciences
| 2021
von
Dalal, R.
|
Ananthakrishnan, A.
|
Hamilton, M.
| +1
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Sprache: Englisch
Filter aufheben
Thema: Remission
Medienart
8
Aufsätze
6
E-Artikel
6
E-Ressourcen
2
Gedruckte Aufsätze
Zeitschriftentitel
8
Digestive diseases and sciences
Thema
8
Anti-TNF
Remission
4
Anti-integrin
4
Biologic
4
Failure
4
Inflammatory bowel disease
4
Inflammatory bowel diseases
4
Non-responder
4
Survival
4
Ulcerative colitis
4
Ustekinumab
2
9RV78Q2002
2
B72HH48FLU
2
Infliximab
2
Journal Article
2
vedolizumab
1
Adalimumab
1
Antibodies, Monoclonal, Humanized
1
Biological Products
1
Case Reports
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
1
2023
3
2022
4
2021
Erscheinungsjahr(e)
Von:
Bis:
Sprache
Englisch
Haven't found what you're looking for?
Wird geladen...